Citation: J. Baniel et al., COST- AND RISK-BENEFIT CONSIDERATIONS IN THE MANAGEMENT OF CLINICAL STAGE-I NONSEMINOMATOUS TESTICULAR-TUMORS, Annals of surgical oncology, 3(1), 1996, pp. 86-93
Citation: Bj. Roth, STRENGTH-INTERVAL CURVES FOR CARDIAC TISSUE PREDICTED USING THE BIDOMAIN MODEL, Journal of cardiovascular electrophysiology, 7(8), 1996, pp. 722-737
Citation: Bj. Roth, HIGHLIGHTS OF ABSTRACTS ON HORMONE-REFRACTORY PROSTATE-CANCER PRESENTED AT THE 1996 ANNUAL-MEETING OF THE AMERICAN-SOCIETY-OF-CLINICAL-ONCOLOGY, Seminars in oncology, 23(6), 1996, pp. 6-7
Citation: Bj. Roth, EFFECT OF A PERFUSING BATH ON THE RATE OF RISE OF AN ACTION-POTENTIALPROPAGATING THROUGH A SLAB OF CARDIAC TISSUE, Annals of biomedical engineering, 24(6), 1996, pp. 639-646
Citation: Bj. Roth et Jp. Wikswo, THE EFFECT OF EXTERNALLY APPLIED ELECTRICAL FIELDS ON MYOCARDIAL TISSUE, Proceedings of the IEEE, 84(3), 1996, pp. 379-391
Authors:
SALERNO SM
ORMSETH EJ
ROTH BJ
MEYER CA
CHRISTENSEN ED
DILLARD TA
Citation: Sm. Salerno et al., SULFASALAZINE PULMONARY TOXICITY IN ULCERATIVE-COLITIS MIMICKING CLINICAL-FEATURES OF WEGENERS GRANULOMATOSIS, Chest, 110(2), 1996, pp. 556-559
Citation: Sm. Salerno et al., EOSINOPHILIC PNEUMONIA AND RESPIRATORY-FAILURE ASSOCIATED WITH A TRAZODONE OVERDOSE, American journal of respiratory and critical care medicine, 152(6), 1995, pp. 2170-2172
Authors:
NAGARAJAN SS
DURAND DM
ROTH BJ
WIJESINGHE RS
Citation: Ss. Nagarajan et al., MAGNETIC STIMULATION OF AXONS IN A NERVE BUNDLE - EFFECTS OF CURRENT REDISTRIBUTION IN THE BUNDLE, Annals of biomedical engineering, 23(2), 1995, pp. 116-126
Citation: Bj. Roth et Df. Bajorin, ADVANCED BLADDER-CANCER - THE NEED TO IDENTIFY NEW AGENTS IN THE POST-M-VAC (METHOTREXATE, VINBLASTINE, DOXORUBICIN AND CISPLATIN) WORLD, The Journal of urology, 153(3), 1995, pp. 894-900
Citation: Bj. Roth, A MATHEMATICAL-MODEL OF MAKE AND BREAK ELECTRICAL-STIMULATION OF CARDIAC TISSUE BY A UNIPOLAR ANODE OR CATHODE, IEEE transactions on biomedical engineering, 42(12), 1995, pp. 1174-1184
Citation: J. Baniel et al., COST AND RISK-BENEFIT IN THE MANAGEMENT OF CLINICAL STAGE-II NONSEMINOMATOUS TESTICULAR-TUMORS, Cancer, 75(12), 1995, pp. 2897-2903
Authors:
NICHOLS CR
FOX EP
ROTH BJ
WILLIAMS SD
LOEHRER PJ
EINHORN LH
Citation: Cr. Nichols et al., INCIDENCE OF NEUTROPENIC FEVER IN PATIENTS TREATED WITH STANDARD-DOSECOMBINATION CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER AND THE COST IMPACT OF TREATMENT WITH GRANULOCYTE-COLONY-STIMULATING FACTOR, Journal of clinical oncology, 12(6), 1994, pp. 1245-1250
Authors:
ROTH BJ
DREICER R
EINHORN LH
NEUBERG D
JOHNSON DH
SMITH JL
HUDES GR
SCHULTZ SM
LOEHRER PJ
Citation: Bj. Roth et al., SIGNIFICANT ACTIVITY OF PACLITAXEL IN ADVANCED TRANSITIONAL-CELL CARCINOMA OF THE UROTHELIUM - A PHASE-II TRIAL OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP, Journal of clinical oncology, 12(11), 1994, pp. 2264-2270